Caseinphosphopeptides

General Information


DRACP ID  DRACP00451

Peptide Name   Caseinphosphopeptides

Sequence  PPPEE

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  Bovine milk

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
AZ-97 Colon carcinoma Carcinoma Inhibition at 24-28 g/l MTT assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antihypertensive; Antiviral; Antioxidant; Immunomodulant



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00451

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C25H37N5O10

Absent amino acids  ACDFGHIKLMNQRSTVWY

Common amino acids  P

Mass  63911

Pl  3.61

Basic residues  0

Acidic residues  2

Hydrophobic residues  0

Net charge  -2

Boman Index  -1362

Hydrophobicity  -236

Aliphatic Index  0

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23533710

Title  Potential anticarcinogenic peptides from bovine milk

Doi 10.1155/2013/939804

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.